Thursday, November 27, 2025

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

G Mining Q3 Earnings: Costs Down, Production Up

Endeavour Silver Q3 Earnings: On The Upswing

Recommended

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Related News

Trump Sets Ten-Day Tariff Clock On Russia To Force Ceasefire With Ukraine

President Donald Trump tightened the screws on Russia, warning that “tariffs and the various things...

Wednesday, July 30, 2025, 02:18:00 PM

Ukraine Pitches Truce With Russia and US Minerals Deal Following Trump Tantrum

Ukrainian President Volodymyr Zelenskyy has offered a limited truce with Russia and signaled his readiness...

Wednesday, March 5, 2025, 12:06:00 PM

Trump Considers Delay on Auto Parts Tariffs

President Donald Trump is considering a temporary delay on auto parts tariffs, a move that...

Thursday, April 17, 2025, 12:52:00 PM

Ghislaine Maxwell Seeks Conviction Reversal as Questions Mount Over Trump-Epstein Connections

Ghislaine Maxwell, the convicted child sex trafficker serving 20 years for facilitating Jeffrey Epstein’s abuse...

Tuesday, July 29, 2025, 04:29:00 PM

Decoding the White House’s Tariff Exceptions

A newly released White House directive has triggered fresh scrutiny of the US tariff landscape,...

Thursday, April 3, 2025, 10:37:00 AM